KABUKI SYNDROME FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,302,196
Investments
71%
Receivables (Non-Related)
16%
Cash & Equivalents
13%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$30,090
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$321,925
$294,057
-9%
Receivables (Non-Related)
$440,146
$360,246
-18%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
$1,284,874
$1,644,186
+28%
Property, Plant, & Equipment (net)
$4,487
$3,707
-17%
Other Assets
-
-
-
Total Assets
$2,051,432
$2,302,196
+12%
Liabilities
2023
2024
Change
Payables & Accruals
$30,972
$30,090
-3%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$30,972
$30,090
-3%
Net assets
2023
2024
Change
Restricted Net Assets
$603,602
$584,565
-3%
Unrestricted Net Assets
$1,416,858
$1,687,541
+19%
Net assets
2023
2024
Change
Net assets
+$2,020,460
+$2,272,106
+12%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)